Vivitrol: Another Option for Opioid Addiction?
The Carlat Addiction Treatment Report, Volume 2, Number 3, May 2014
https://www.thecarlatreport.com/newsletter-issue/catrv2n3/
Issue Links: Learning Objectives | Editorial Information
Topics: Addiction | Psychopharmacology Tips
David A. Frenz, MD
Naltrexone first hit the US market as an oral medication (ReVia) way back in 1984. Over the years, it developed a solid reputation for treating alcoholism and remains a first-line therapy today. Naltrexone was a bust, however, when it came to treating opioid addiction.
You can't view details of this content, please login or buy subscription here
David A. Frenz, MD
Medical Director, Addiction Medicine, HealthEast Care System, St. Paul, MN, Editor-in-chief, The Carlat Addiction Treatment Report
Dr. Frenz has disclosed that he has no relevant relationships or financial interests in any commercial company related to this educational activity.